Lack of the lectin-like domain of thrombomodulin worsens shiga toxin-associated hemolytic uremic syndrome in mice

Carlamaria Zoja, Monica Locatelli, Chiara Pagani, Daniela Corna, Cristina Zanchi, Berend Isermann, Giuseppe Remuzzi, Edward M. Conway, Marina Noris

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Shiga toxin (Stx)-producing Escherichia coli is a primary cause of diarrhea-associated hemolytic uremic syndrome (HUS), a disorder of thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure. The pathophysiology of renal microvascular thrombosis in Stx-HUS is still ill-defined. Based on evidence that abnormalities in thrombomodulin (TM), an anticoagulant endothelial glycoprotein that modulates complement and inflammation, predispose to atypical HUS, we assessed whether impaired TM function may adversely affect evolution of Stx-HUS. Disease was induced by coinjection of Stx2/LPS in wild-type mice (TMwt/wt) and mice that lack the lectin-like domain of TM (TMLeD/LeD), which is critical for its anti-inflammatory and cytoprotective properties. After Stx2/LPS, TM LeD/LeD mice exhibited more severe thrombocytopenia and renal dysfunction than TMwt/wt mice. Lack of lectin-like domain of TM resulted in a stronger inflammatory reaction after Stx2/LPS with more neutrophils and monocytes/macrophages infiltrating the kidney, associated with PECAM-1 and chemokine upregulation. After Stx2/LPS, intraglomerular fibrin(ogen) deposits were detected earlier in TMLeD/LeD than in TM wt/wt mice. More abundant fibrin(ogen) deposits were also found in brain and lungs. Under basal conditions, TMLeD/LeD mice exhibited excess glomerular C3 deposits, indicating impaired complement regulation in the kidney that could lead to local accumulation of proinflammatory products. TMLeD/LeD mice with HUS had a higher mortality rate than TM wt/wt mice. If applicable to humans, these findings raise the possibility that genetic or acquired TM defects might have an impact on the severity of microangiopathic lesions after exposure to Stx-producing E. coli infections and raise the potential for using soluble TM in the treatment of Stx-HUS.

Original languageEnglish
Pages (from-to)3661-3668
Number of pages8
JournalJournal of Immunology
Volume189
Issue number7
DOIs
Publication statusPublished - Oct 1 2012

Fingerprint

Shiga Toxin
Thrombomodulin
Hemolytic-Uremic Syndrome
Lectins
Kidney
Fibrin
Thrombocytopenia
CD31 Antigens
Shiga-Toxigenic Escherichia coli
Escherichia coli Infections
Hemolytic Anemia
Chemokines
Acute Kidney Injury
Anticoagulants
Monocytes
Diarrhea
Glycoproteins
Neutrophils
Thrombosis
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Immunology

Cite this

Lack of the lectin-like domain of thrombomodulin worsens shiga toxin-associated hemolytic uremic syndrome in mice. / Zoja, Carlamaria; Locatelli, Monica; Pagani, Chiara; Corna, Daniela; Zanchi, Cristina; Isermann, Berend; Remuzzi, Giuseppe; Conway, Edward M.; Noris, Marina.

In: Journal of Immunology, Vol. 189, No. 7, 01.10.2012, p. 3661-3668.

Research output: Contribution to journalArticle

Zoja, Carlamaria ; Locatelli, Monica ; Pagani, Chiara ; Corna, Daniela ; Zanchi, Cristina ; Isermann, Berend ; Remuzzi, Giuseppe ; Conway, Edward M. ; Noris, Marina. / Lack of the lectin-like domain of thrombomodulin worsens shiga toxin-associated hemolytic uremic syndrome in mice. In: Journal of Immunology. 2012 ; Vol. 189, No. 7. pp. 3661-3668.
@article{164a836961744f09bbe4f2317300beeb,
title = "Lack of the lectin-like domain of thrombomodulin worsens shiga toxin-associated hemolytic uremic syndrome in mice",
abstract = "Shiga toxin (Stx)-producing Escherichia coli is a primary cause of diarrhea-associated hemolytic uremic syndrome (HUS), a disorder of thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure. The pathophysiology of renal microvascular thrombosis in Stx-HUS is still ill-defined. Based on evidence that abnormalities in thrombomodulin (TM), an anticoagulant endothelial glycoprotein that modulates complement and inflammation, predispose to atypical HUS, we assessed whether impaired TM function may adversely affect evolution of Stx-HUS. Disease was induced by coinjection of Stx2/LPS in wild-type mice (TMwt/wt) and mice that lack the lectin-like domain of TM (TMLeD/LeD), which is critical for its anti-inflammatory and cytoprotective properties. After Stx2/LPS, TM LeD/LeD mice exhibited more severe thrombocytopenia and renal dysfunction than TMwt/wt mice. Lack of lectin-like domain of TM resulted in a stronger inflammatory reaction after Stx2/LPS with more neutrophils and monocytes/macrophages infiltrating the kidney, associated with PECAM-1 and chemokine upregulation. After Stx2/LPS, intraglomerular fibrin(ogen) deposits were detected earlier in TMLeD/LeD than in TM wt/wt mice. More abundant fibrin(ogen) deposits were also found in brain and lungs. Under basal conditions, TMLeD/LeD mice exhibited excess glomerular C3 deposits, indicating impaired complement regulation in the kidney that could lead to local accumulation of proinflammatory products. TMLeD/LeD mice with HUS had a higher mortality rate than TM wt/wt mice. If applicable to humans, these findings raise the possibility that genetic or acquired TM defects might have an impact on the severity of microangiopathic lesions after exposure to Stx-producing E. coli infections and raise the potential for using soluble TM in the treatment of Stx-HUS.",
author = "Carlamaria Zoja and Monica Locatelli and Chiara Pagani and Daniela Corna and Cristina Zanchi and Berend Isermann and Giuseppe Remuzzi and Conway, {Edward M.} and Marina Noris",
year = "2012",
month = "10",
day = "1",
doi = "10.4049/jimmunol.1102118",
language = "English",
volume = "189",
pages = "3661--3668",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - Lack of the lectin-like domain of thrombomodulin worsens shiga toxin-associated hemolytic uremic syndrome in mice

AU - Zoja, Carlamaria

AU - Locatelli, Monica

AU - Pagani, Chiara

AU - Corna, Daniela

AU - Zanchi, Cristina

AU - Isermann, Berend

AU - Remuzzi, Giuseppe

AU - Conway, Edward M.

AU - Noris, Marina

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Shiga toxin (Stx)-producing Escherichia coli is a primary cause of diarrhea-associated hemolytic uremic syndrome (HUS), a disorder of thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure. The pathophysiology of renal microvascular thrombosis in Stx-HUS is still ill-defined. Based on evidence that abnormalities in thrombomodulin (TM), an anticoagulant endothelial glycoprotein that modulates complement and inflammation, predispose to atypical HUS, we assessed whether impaired TM function may adversely affect evolution of Stx-HUS. Disease was induced by coinjection of Stx2/LPS in wild-type mice (TMwt/wt) and mice that lack the lectin-like domain of TM (TMLeD/LeD), which is critical for its anti-inflammatory and cytoprotective properties. After Stx2/LPS, TM LeD/LeD mice exhibited more severe thrombocytopenia and renal dysfunction than TMwt/wt mice. Lack of lectin-like domain of TM resulted in a stronger inflammatory reaction after Stx2/LPS with more neutrophils and monocytes/macrophages infiltrating the kidney, associated with PECAM-1 and chemokine upregulation. After Stx2/LPS, intraglomerular fibrin(ogen) deposits were detected earlier in TMLeD/LeD than in TM wt/wt mice. More abundant fibrin(ogen) deposits were also found in brain and lungs. Under basal conditions, TMLeD/LeD mice exhibited excess glomerular C3 deposits, indicating impaired complement regulation in the kidney that could lead to local accumulation of proinflammatory products. TMLeD/LeD mice with HUS had a higher mortality rate than TM wt/wt mice. If applicable to humans, these findings raise the possibility that genetic or acquired TM defects might have an impact on the severity of microangiopathic lesions after exposure to Stx-producing E. coli infections and raise the potential for using soluble TM in the treatment of Stx-HUS.

AB - Shiga toxin (Stx)-producing Escherichia coli is a primary cause of diarrhea-associated hemolytic uremic syndrome (HUS), a disorder of thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure. The pathophysiology of renal microvascular thrombosis in Stx-HUS is still ill-defined. Based on evidence that abnormalities in thrombomodulin (TM), an anticoagulant endothelial glycoprotein that modulates complement and inflammation, predispose to atypical HUS, we assessed whether impaired TM function may adversely affect evolution of Stx-HUS. Disease was induced by coinjection of Stx2/LPS in wild-type mice (TMwt/wt) and mice that lack the lectin-like domain of TM (TMLeD/LeD), which is critical for its anti-inflammatory and cytoprotective properties. After Stx2/LPS, TM LeD/LeD mice exhibited more severe thrombocytopenia and renal dysfunction than TMwt/wt mice. Lack of lectin-like domain of TM resulted in a stronger inflammatory reaction after Stx2/LPS with more neutrophils and monocytes/macrophages infiltrating the kidney, associated with PECAM-1 and chemokine upregulation. After Stx2/LPS, intraglomerular fibrin(ogen) deposits were detected earlier in TMLeD/LeD than in TM wt/wt mice. More abundant fibrin(ogen) deposits were also found in brain and lungs. Under basal conditions, TMLeD/LeD mice exhibited excess glomerular C3 deposits, indicating impaired complement regulation in the kidney that could lead to local accumulation of proinflammatory products. TMLeD/LeD mice with HUS had a higher mortality rate than TM wt/wt mice. If applicable to humans, these findings raise the possibility that genetic or acquired TM defects might have an impact on the severity of microangiopathic lesions after exposure to Stx-producing E. coli infections and raise the potential for using soluble TM in the treatment of Stx-HUS.

UR - http://www.scopus.com/inward/record.url?scp=84866544002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866544002&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1102118

DO - 10.4049/jimmunol.1102118

M3 - Article

C2 - 22942429

AN - SCOPUS:84866544002

VL - 189

SP - 3661

EP - 3668

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -